Compugen Reports Third Quarter 2019 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Compugen Reports Third Quarter 2019 Results

Compugen (CGEN) Reports In-Line Q3 EPS

November 11, 2019 7:04 AM EST

Compugen (NASDAQ: CGEN) reported Q3 EPS of ($0.10), in-line with the analyst estimate of ($0.10).

"Our first presentation of clinical data last week at SITC 2019 is an important milestone for Compugen," said Anat Cohen-Dayag, Ph.D., President and CEO of Compugen. "We are encouraged by the initial signals of anti-tumor activity seen with COM701, a first-in-class PVRIG inhibitor, in the monotherapy dose escalation arm of the study treating a... More